Dose-response relationship of topically applied mitomycin C for the prevention of laser myringotomy closure

Abstract

There is a dose-response curve for topical mitomycin C when used for prolonging myringotomy patency in doses up to 0.4 mg/mL. Higher doses do not appear to prolong patency and are associated with greater otorrhea, suggesting middle ear toxicity.